3 billion anti-infective injections, Colum Pharmaceuticals successfully entered

Pharmaceutical Network May 29th, May 25, the official website of the State Drug Administration showed that The injection of Melosilin sodium subatan sodium of Colum Pharmaceuticals, a subsidiary of Colum Pharmaceuticals, was approved for production, becoming the eighth approved generic drug in ChinaMinet data show that the product in 2019 China's public medical institutions terminal sales of 2,963 million yuan, there is no enterprise declaration consistency evaluationinjection with melosilin sodium subatin sodium (4:1) as chimycin-type broad-spectrum antibiotic melosilin sodium and beta-lactamase inhibitor shubatan sodium at a ratio of 4:1 compound preparation, suitable for the production of enzyme-resistant bacteria caused by moderate to severe infectious, including respiratory infections, urinary system infectionsFigure 1: 2015-2019 China's public medical institutions terminal injection with meloline sodium shubatan sodium (4:1) sales (units: million yuan)meters of intranet data show that the limited resistance and other policy impact, Sales of milosilin sodium shubatan (4:1) for injection in 2019 fell to 2,963 million yuan in china's urban public, county-level public hospitals, urban community centers, and township hospitals (China's public medical institutions) in 2019Figure 2: 2019 China's public medical institutions terminal injection with melosilin sodium shubatan (4:1) manufacturers competition pattern
including Hunan Colum Pharmaceuticals, the current domestic market has 8 generic pharmaceutical enterprises have injection of meloxilin sodium shubatan sodium (4:1) production approvalIn 2019 China's public medical institutions terminal manufacturers competition pattern, Ruiyang Pharmaceuticals occupies "half of the mountain", Shanxi YuyuanGroup with 23.61 percent of the market sharemeter net data show that there are noin the country to submit injection with meloline sodium shubatan sodium (4:1) consistency evaluation supplement application or registered with the new classification of production, which enterprise will take the lead in the layout? The mine net will continue to follow upsources: Minet database, the State Drug Administrationnote: data statistics as of May 28, if there are omissions, welcome to point the finger!